Eli Lilly Diabetes, Obesity Head to Retire
Wall Street Journal
The head of Eli Lilly’s burgeoning diabetes and obesity franchise is retiring at the end of the year. Mike Mason is leaving after 34 years with the company.
https://www.wsj.com/articles/eli-lilly-diabetes-obesity-head-mike-mason-to-retire-a0848b79